News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Chromatin, Inc. Licenses Gene Stacking Technology for Sugar cane to Syngenta Corporation
June 26, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHICAGO--(BUSINESS WIRE)--Chromatin Inc. announced today that it has entered into an exclusive worldwide research and commercial license agreement with Syngenta Biotechnology Inc. for Chromatin’s proprietary gene stacking technology in sugar cane.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Layoff Tracker
Replimune’s ‘challenging path forward’ will include job cuts
April 14, 2026
·
47 min read
·
BioSpace Editorial Staff
Earnings
With nearly a quarter billion in Q1, J&J targets $100B revenue in 2026
April 14, 2026
·
3 min read
·
Heather McKenzie
Manufacturing
Lilly investing billions to prepare for overseas oral GLP-1 launches
April 14, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Lilly wants to bridge cancer care gap with $300M ADC biotech buy
April 14, 2026
·
1 min read
·
Gabrielle Masson